Skip to main content
Cell Bio Human Tech Co., Ltd logo

Cell Bio Human Tech Co., Ltd — Investor Relations & Filings

Ticker · 318160 ISIN · KR7318160009 KO Professional, scientific and technical activities
Open in API
Filings indexed 146 across all filing types
Latest filing 2023-01-26 M&A Activity
Country KR South Korea
Listing KO 318160

About Cell Bio Human Tech Co., Ltd

http://cellbiohumantech.co.kr/en/

Cell Bio Human Tech Co., Ltd. is a company that develops and manufactures advanced nonwoven fabrics for the cosmetics sector. Utilizing cellulose reaction technology, the company produces specialized materials primarily for sheet masks and skincare pads. Its products, derived from various cellulose fibers, are engineered for differentiated performance, offering features such as high transparency and adhesion. The company provides customizable and eco-friendly fabric solutions, with key product lines including PT Cell and S Cell.

Recent filings

Filing Released Lang Actions
[기재정정]증권신고서(합병)
M&A Activity Classification · 95% confidence The document is a '증권신고서(합병)' (Securities Registration Statement for Merger) which is a regulatory filing in South Korea. It details the correction (정정) of a previously submitted merger registration statement, specifically updating financial projections, revenue estimates, and risk factors related to the merger. This falls under the category of regulatory filings for corporate actions.
2023-01-26 Korean
[기재정정]증권신고서(합병)
M&A Activity Classification · 100% confidence The document is a '증권신고서(합병) 정정신고' (Amendment to Securities Registration Statement for Merger). It details specific corrections made to a previously filed merger registration statement, including updates to financial statements (incorporating 2022 Q3 results), revenue projections, and merger schedules. This is a formal regulatory filing related to M&A activity, specifically a registration statement amendment, which falls under the category of M&A Activity (TAR).
2023-01-16 Korean
증권신고서(합병)
M&A Activity Classification · 95% confidence The document is a '증권신고서(합병)' (Securities Registration Statement for Merger) filed with the Financial Services Commission (FSC) in South Korea. It details the merger between Cellbiohumantech Co., Ltd. and Daishin Balance No. 12 SPAC. This type of document is a formal regulatory filing required for corporate mergers and acquisitions involving public companies, which falls under the category of 'Regulatory Filings' (RNS) as it is a comprehensive legal disclosure document rather than a simple announcement or a standard financial report.
2023-01-05 Korean
감사보고서 (2021.12)
Audit Report / Information Classification · 100% confidence The document is a formal 'Audit Report' (감사보고서) for the company 'CellBioHumantech' (주식회사 셀바이오휴먼텍) for the fiscal year ending December 31, 2021. It includes the independent auditor's report from Samil PricewaterhouseCoopers, the financial statements (Balance Sheet, Income Statement, Statement of Changes in Equity, Cash Flow Statement), and detailed notes. While it contains financial data, it is a formal audit report rather than a standalone annual report (10-K) or a simple earnings release. Given the specific category 'Audit Report / Information' (AR), this is the most accurate classification. FY 2021
2022-03-31 Korean
연결감사보고서 (2021.12)
Audit Report / Information Classification · 98% confidence The document is a comprehensive 'Audit Report' (감사보고서) for CellBioHumantech, covering the fiscal years 2020 and 2021. It includes the independent auditor's report, consolidated financial statements (balance sheet, income statement, statement of changes in equity, cash flow statement), and detailed notes to the financial statements. While it contains financial data, it is a formal audit report rather than a full Annual Report (10-K) or a simple earnings release. It fits the definition of an Audit Report (AR) as it provides the auditor's opinion and the audited financial statements. FY 2021
2022-03-31 Korean
감사보고서 (2020.12)
Annual Report Classification · 100% confidence The document is a comprehensive 'Audit Report' (감사보고서) for the company 'CellBioHumanTech' (주식회사 셀바이오휴먼텍) for the fiscal year ending December 31, 2020. It includes the independent auditor's report, financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes to the financial statements. This constitutes a full annual financial report, which falls under the 'Annual Report' (10-K) category in the provided schema, as it contains the complete audited financial package for the fiscal year. FY 2020
2021-03-30 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.